SCHEMBL3400917

SCHEMBL3400917

c1ccc2c(-c3ncc(CN4CCC(N5CCCCC5)CC4)[nH]3)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
RECQL P46063 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SIGMAR1 Q99720 3/20 0.41
DRD2 P14416 3/20 0.41
DRD4 P21917 3/20 0.41
DRD3 P35462 2/20 0.41
HRH3 Q9Y5N1 2/20 0.40
MBTD1 Q05BQ5 1/20 0.40
L3MBTL3 Q96JM7 1/20 0.40
HTR1A P08908 1/20 0.39
HTR3A P46098 1/20 0.39
PARP1 P09874 4/20 0.38
KMT2A Q03164 1/20 0.38
CYP2D6 P10635 1/20 0.38
NPY1R P25929 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
OPRL1 P41146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405212 0.90 SIGMAR1 (0.49) ALDH1A1TSHRSIGMAR1DRD2DRD4
SCHEMBL3403443 0.90 SIGMAR1 (0.47) ALDH1A1SIGMAR1DRD2DRD4DRD3
SCHEMBL3404406 0.87 SIGMAR1 (0.43) ALDH1A1TSHRSIGMAR1DRD2DRD4
SCHEMBL3405477 0.85 SIGMAR1 (0.42) ALDH1A1TSHRSIGMAR1DRD2DRD4
SCHEMBL3397927 0.81 DRD4 (0.46) ALDH1A1TSHRSIGMAR1DRD2DRD4
SCHEMBL3399467 0.77 DRD4 (0.46) L3MBTL1DRD2DRD4DRD3HTR1A
SCHEMBL3403856 0.77 DRD4 (0.43) ALDH1A1TSHRL3MBTL1SIGMAR1DRD2
SCHEMBL3399872 0.77 CYP2D6 (0.47) ALDH1A1TSHRL3MBTL1SIGMAR1DRD2
SCHEMBL3400725 0.77 ALDH1A1 (0.43) ALDH1A1TSHRSIGMAR1DRD2DRD4
SCHEMBL3405592 0.77 CYP2D6 (0.47) ALDH1A1TSHRL3MBTL1SIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
WO-2006089076-A9 THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES NEUROGEN CORP (US) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 ALDH1A1 916/4885TSHR 18/4885RECQL 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.